Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Aug;41(8):1812–1814. doi: 10.1128/aac.41.8.1812

In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles.

F Barchiesi 1, L Falconi Di Francesco 1, G Scalise 1
PMCID: PMC164012  PMID: 9257768

Abstract

A checkerboard microdilution method was applied to study the in vitro interaction of terbinafine with either fluconazole and itraconazole against 30 strains of Candida albicans. Synergy was observed in 40% of the terbinafine-fluconazole interactions and in 43% of the terbinafine-itraconazole interactions, while antagonism was not observed. Even when only additivity was achieved, the combinations still showed beneficial effects since at least twofold reductions in the MICs of both drugs were found in 100% of the terbinafine-fluconazole interactions and in 76% of the terbinafine-itraconazole interactions.

Full Text

The Full Text of this article is available as a PDF (157.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anaissie E., Paetznick V., Bodey G. P. Fluconazole susceptibility testing of Candida albicans: microtiter method that is independent of inoculum size, temperature, and time of reading. Antimicrob Agents Chemother. 1991 Aug;35(8):1641–1646. doi: 10.1128/aac.35.8.1641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Balfour J. A., Faulds D. Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses. Drugs. 1992 Feb;43(2):259–284. doi: 10.2165/00003495-199243020-00010. [DOI] [PubMed] [Google Scholar]
  3. Barchiesi F., Colombo A. L., McGough D. A., Rinaldi M. G. Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard. J Clin Microbiol. 1994 Oct;32(10):2494–2500. doi: 10.1128/jcm.32.10.2494-2500.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Barchiesi F., Del Poeta M., Morbiducci V., Ancarani F., Scalise G. Turbidimetric and visual criteria for determining the in vitro activity of six antifungal agents against Candida spp. and Cryptococcus neoformans. Mycopathologia. 1993 Oct;124(1):19–25. doi: 10.1007/BF01103052. [DOI] [PubMed] [Google Scholar]
  5. Barchiesi F., Hollis R. J., McGough D. A., Scalise G., Rinaldi M. G., Pfaller M. A. DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDS. Clin Infect Dis. 1995 Mar;20(3):634–640. doi: 10.1093/clinids/20.3.634. [DOI] [PubMed] [Google Scholar]
  6. Barchiesi F., Najvar L. K., Luther M. F., Scalise G., Rinaldi M. G., Graybill J. R. Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis model. Antimicrob Agents Chemother. 1996 May;40(5):1317–1320. doi: 10.1128/aac.40.5.1317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Boken D. J., Swindells S., Rinaldi M. G. Fluconazole-resistant Candida albicans. Clin Infect Dis. 1993 Dec;17(6):1018–1021. doi: 10.1093/clinids/17.6.1018. [DOI] [PubMed] [Google Scholar]
  8. Kovarik J. M., Mueller E. A., Zehender H., Denouël J., Caplain H., Millerioux L. Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites. Antimicrob Agents Chemother. 1995 Dec;39(12):2738–2741. doi: 10.1128/aac.39.12.2738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Nguyen M. H., Barchiesi F., McGough D. A., Yu V. L., Rinaldi M. G. In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans. Antimicrob Agents Chemother. 1995 Aug;39(8):1691–1695. doi: 10.1128/aac.39.8.1691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Petranyi G., Meingassner J. G., Mieth H. Antifungal activity of the allylamine derivative terbinafine in vitro. Antimicrob Agents Chemother. 1987 Sep;31(9):1365–1368. doi: 10.1128/aac.31.9.1365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pfaller M. A., Bale M., Buschelman B., Lancaster M., Espinel-Ingroff A., Rex J. H., Rinaldi M. G. Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methods. J Clin Microbiol. 1994 Jul;32(7):1650–1653. doi: 10.1128/jcm.32.7.1650-1653.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Pfaller M. A., Messer S. A., Coffmann S. Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution methods to test five antifungal agents, including the new triazole D0870. J Clin Microbiol. 1995 May;33(5):1094–1097. doi: 10.1128/jcm.33.5.1094-1097.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Redding S., Smith J., Farinacci G., Rinaldi M., Fothergill A., Rhine-Chalberg J., Pfaller M. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis. 1994 Feb;18(2):240–242. doi: 10.1093/clinids/18.2.240. [DOI] [PubMed] [Google Scholar]
  14. Rex J. H., Pfaller M. A., Lancaster M., Odds F. C., Bolmström A., Rinaldi M. G. Quality control guidelines for National Committee for Clinical Laboratory Standards--recommended broth macrodilution testing of ketoconazole and itraconazole. J Clin Microbiol. 1996 Apr;34(4):816–817. doi: 10.1128/jcm.34.4.816-817.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sanguineti A., Carmichael J. K., Campbell K. Fluconazole-resistant Candida albicans after long-term suppressive therapy. Arch Intern Med. 1993 May 10;153(9):1122–1124. [PubMed] [Google Scholar]
  16. Yu V. L., Zuravleff J. J., Bornholm J., Archer G. In-vitro synergy testing of triple antibiotic combinations against Staphylococcus epidermidis isolates from patients with endocarditis. J Antimicrob Chemother. 1984 Oct;14(4):359–366. doi: 10.1093/jac/14.4.359. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES